Our bold ambition
Bringing life-changing medicines to patients sooner.
At Day One, we are focused on advancing first- or best-in-class medicines for childhood and adult diseases with equal intensity.
We were founded to address the lack of new therapies resulting from the traditional drug development model, that has left children with cancer and their families waiting too long for new, life-changing treatments. Our aim is to accelerate better, targeted treatments so patients of any age can look forward from ‘day one’ to the future they’ve envisioned.
Our Mission
Inspired by the urgent needs of children, Day One creatively and intentionally develops new medicines for people of all ages with life-threatening diseases.
“Our goal is to expand the breadth and pace of drug development, and in so doing, fundamentally change the way novel medicines reach children and adults.”
Chief Executive Officer
Day One Facts
2018
The year Day One was founded.
2024
Our first FDA-approved medicine for pediatric brain tumors.
55+
Medical, clinical, & research oncology professionals.
